In his follow-up to Sapiens, Yuval Noah Harari envisions what a 'useless class' of humans might look like as AI advances and spreads - "I'm aware that these kinds of forecasts have been around for at least 200 years, from the beginning of the Industrial Revolution, and they never came true so far. It's basically the boy who cried wolf, but in the original story of the boy who cried wolf, in the end, the wolf actually comes, and I think that is true this time." [more inside]
How The Economic Machine Works by Ray Dalio actually makes a case against austerity and for redistribution, but also for money printing (and, arguably, for bailouts), while stressing the need to keep making productivity-improving public and private investments. However, it could be equally entitled: How The Industrial Age Political-Economy Doesn't Work Anymore, viz. Surviving Progress (2011)... [more inside]
How Corporations Corrupt Science at the Public's Expense: Report looks at methods of corporate abuse, suggests steps toward reform [Full Report (PDF)] [Executive Summary (PDF)] [more inside]
Right Wing astroturfing A non-scientific analysis of the patterns in forum board discussions on a variety of topics. The gist: discussions of issues in which there's money at stake (like climate change, public health and corporate tax avoidance) are often characterised by amazing levels of abuse and disruption by rightwing libertarians who are pro-corporate, anti-tax, anti-regulation. Discussions of issues in which there's little money at stake tend to be a lot more civilised than debates about issues where companies stand to lose or gain billions.
Merchants of Doubt is a new book that reports how a small group of scientists committed to an extreme free-market ideology have been employed by large corporations over several decades to cast doubt on such different environmental issues as the risks of tobacco smoke, the dangers of DDT, the effectiveness of the Strategic Defence Initiative, the regulation of CFCs, and the causes of global warming. A review in the Christian Science Monitor calls this "one of the most important books of the year. Exhaustively researched and documented..."
Cheap, safe drug kills most cancers. That's the good news. The bad news is that because there's no patent and it's so cheap to make, researchers may not be able to get funding from the private sector for further research since the treatment wouldn't make a profit. [Via Hullabaloo.]